Biotechnology innovator Molecular Circuitry, Inc. has announced today that it will sell its new Detex(TM) Pathogen Detection System direct to the food industry and other markets in North America. Previously, the Detex system was marketed through distributor channels."This change in marketing strategy will allow us to lower the price of the system and more aggressively pursue our sales targets in the food industry," said Herbert Lotman, president of Molecular Circuitry, Inc. "From the start, Molecular Circuitry has had the expertise and technical background to educate potential buyers about the unique advantages of the new system. Now, by dedicating new resources, we can deploy a direct sales force to actively take the Detex message to the many companies that can benefit from this revolutionary technology."The Detex Pathogen Detection System is a self-contained, automated testing instrument using patented detection methods and a new proprietary growth medium to test for contaminants in meat, poultry and other types of perishable food. Unlike other systems, Detex can simultaneously test for multiple pathogens, such as E.coli O157 (including H7), Salmonella and Campylobacter and Listeria.Molecular Circuitry Inc., a biotechnology company based in King of Prussia, PA, designs and manufactures automated instruments and assay kits for the rapid detection of pathogenic organisms.For more information on the Detex Pathogen Detection System, contact Molecular Circuitry at 1-877-77DETEX or visit their web site at